3D Dose Distribution Visualization Using Point Cloud Overlays

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current user interfaces for medical interventions, such as radiotherapy and ablation therapy, provide only two-dimensional slices that are difficult to analyze and lack intuitive visualization of how a theoretical three-dimensional treatment dose distribution interacts with the target body area, making it challenging for doctors to optimize treatment delivery.

Innovation Solution

A computer-implemented method that generates a cloud of points with distinct displaying characteristics, such as shape, size, intensity, and transparency, overlaid on a three-dimensional model to enhance visualization of treatment plan data, allowing better perception of depth and interaction with anatomical structures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Area of stationary object

If a continuous colored overlay is used to represent treatment dose distribution, then the visualization covers the entire dose distribution area, but the visibility of underlying anatomical structures and depth differentiation is reduced

Engineering Contradiction:
Improvecoverage area of dose distribution visualizationVSAvoidvisibility of underlying structures and depth information
Core Design Contradiction:
Area of stationary objectVSLoss of information

Solution Approach 1:

The continuous colored overlay is segmented into discrete point cloud elements. Each point represents a specific dose value or range, and the points are distributed throughout the 3D space. This segmentation allows the underlying anatomical structures to remain visible while still conveying the complete dose distribution pattern through the spatial arrangement and density of points.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses color variations in the point cloud to represent different dose levels. Points are colored according to their associated dose values, creating a visual gradient that indicates dose intensity without requiring a continuous opaque overlay. This color-coding system preserves depth information and underlying structure visibility while maintaining comprehensive dose distribution visualization.

Inventive Principle:
Principle #32Color changes

2Device complexity

If two-dimensional slices are used to display treatment dose distribution, then the device complexity is reduced, but the intuitive understanding of three-dimensional dose localization is compromised

Engineering Contradiction:
Improvesimplicity of display interfaceVSAvoidintuitive visualization of 3D dose distribution
Core Design Contradiction:
Device complexityVSEase of operation

Solution Approach 1:

The patent transitions from 2D slice representations to a 3D point cloud visualization. Points are positioned in three-dimensional space with coordinates that reflect their spatial location within the treatment volume. This dimensional enhancement provides intuitive depth perception and spatial localization of dose distribution, allowing physicians to understand the 3D pattern without excessive interface complexity.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Device complexity

If landmarks are displayed with identical characteristics regardless of depth, then the visualization is simpler, but the depth perception and differentiation between structures at different depths is lost

Engineering Contradiction:
Improveuniformity of landmark displayVSAvoiddepth perception accuracy
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent applies different visual characteristics to landmarks based on their depth position. Points closer to the viewer may be displayed with different size, intensity, or color saturation compared to points at greater depths. This local differentiation enhances depth perception and allows physicians to distinguish between structures at various depths within the treatment volume, while the overall system remains relatively simple.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20260108762A1Computer-implemented method for medical guidance of a user in the validation of a treatment dose distribution provided by a treatment planning system
Publication Date: 2026.04.23 AVATAR MEDICAL
  • US20260108762A1 patent drawing
  • US20260108762A1 patent drawing
  • US20260108762A1 patent drawing

AI summary

A computer-implemented method for medical guidance of a user in the validation of a treatment dose distribution provided by a treatment planning system.